Literature DB >> 23719728

[Cervical, inguinal and abdominal lymphnode dissection].

T W Kraus1, K Suna, S Berkhoff, E Jäger, U Kraus-Tiefenbacher.   

Abstract

Diagnostic lymph node dissections can be defined as a form of oncological service surgery. These procedures aim at clarification of differential diagnoses of local or systemic lymph node pathologies or contribute to tumor staging. Procedure implementation can either involve incisional biopsy, selective lymph node extirpation or regional systematic lymph node dissection. Sentinel lymph node lymphadenectomy is a focused form of selective lymphadenectomy. Both surgeon and oncologist must have a preoperative consensus and mutual understanding about the detailed purpose of the procedure in the individual patient setting. Terminology conventions must be considered in communication. Potential reasons to extend surgery should be strategically reflected prior to surgery. Interventional techniques and minimally invasive forms of surgical lymph node dissection must be technically taken into account in order to reduce procedural morbidity. Clinically indicative scenarios, pathophysiological concepts and technical options of surgical lymph node dissection are described and discussed for various anatomical regions.

Entities:  

Mesh:

Year:  2013        PMID: 23719728     DOI: 10.1007/s00104-012-2412-9

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  12 in total

1.  Feasibility of a novel approach to inguinal lymphadenectomy: minimally invasive groin dissection for melanoma.

Authors:  Keith A Delman; David A Kooby; Kenneth Ogan; Wayland Hsiao; Viraj Master
Journal:  Ann Surg Oncol       Date:  2010-03       Impact factor: 5.344

Review 2.  Positive lymph nodes do not metastasize.

Authors:  Jutta Engel; Rebecca T Emeny; Dieter Hölzel
Journal:  Cancer Metastasis Rev       Date:  2012-06       Impact factor: 9.264

Review 3.  Significance and mechanism of lymph node metastasis in cancer progression.

Authors:  Kenji Kawada; Makoto M Taketo
Journal:  Cancer Res       Date:  2011-01-06       Impact factor: 12.701

4.  [Lymphadenectomy of the inguinal region and pelvis].

Authors:  P M Vogt; L-W Lahoda; M Meyer-Marcotty; M Spies; K H Busch
Journal:  Chirurg       Date:  2007-03       Impact factor: 0.955

Review 5.  Completion lymph node dissection after a positive sentinel node: no longer a must?

Authors:  Augustinus P T van der Ploeg; Alexander C J van Akkooi; Cornelis Verhoef; Alexander M M Eggermont
Journal:  Curr Opin Oncol       Date:  2013-03       Impact factor: 3.645

6.  Minimally invasive inguinal lymphadenectomy via endoscopic groin dissection: comprehensive assessment of immediate and long-term complications.

Authors:  Viraj A Master; S Mohammad A Jafri; Kelvin A Moses; Kenneth Ogan; David A Kooby; Keith A Delman
Journal:  J Urol       Date:  2012-08-15       Impact factor: 7.450

Review 7.  Role of lymphadenectomy in surgical treatment of solid tumors: an update on the clinical data.

Authors:  James E Gervasoni; Samer Sbayi; Blake Cady
Journal:  Ann Surg Oncol       Date:  2007-06-28       Impact factor: 5.344

8.  Inguinal lymph node dissection: epidermal vacuum therapy for prevention of wound complications.

Authors:  Robert Tauber; Sebastian Schmid; Thomas Horn; Mark Thalgott; Matthias Heck; Bernhard Haller; Hubert Kübler; Michael Autenrieth; Margitta Retz; Jürgen E Gschwend; Tobias Maurer
Journal:  J Plast Reconstr Aesthet Surg       Date:  2012-10-26       Impact factor: 2.740

9.  A prospective randomized trial: the influence of intraoperative application of fibrin glue after radical inguinal/iliacal lymph node dissection on postoperative morbidity.

Authors:  H Neuss; W Raue; G Koplin; W Schwenk; C Reetz; J W Mall
Journal:  Eur J Surg Oncol       Date:  2008-11-17       Impact factor: 4.424

10.  Modified inguinal lymphadenectomy for carcinoma of the penis with preservation of saphenous veins: technique and preliminary results.

Authors:  W J Catalona
Journal:  J Urol       Date:  1988-08       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.